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ABSTRACT
DIFFERENCES IN NUTRITIONAL OUTCOME MEASURES BETWEEN
PREADOLESCENTS AND ADOLECENTS WITH ANOREXIA NERVOSA WHO
RECEIVED A NASOGASTRIC FEEDING TUBE VERSUS ORAL DIET UPON HOSPITAL
ADMISSION
by
Paige E. Herring
Background: Anorexia nervosa (AN) is a disease defined by an extreme weight loss due to an
intense fear of gaining weight, and it is the third most chronic disease in adolescent females.
Hospitalizations are common among patients with AN due to the major consequences that can
arise from this disease. Most of the complications can be resolved with significant weight gain,
so hospitals have an implemented feeding protocols to optimize weight gain. Studies have shown
that nasogastric (NG) feedings have resulted in a greater weight gain and reduced length of stay
without significant side effects.
Objective: The purpose of this study is to examine the association between demographic and
clinical characteristics and mode of nutrition therapy (oral feeding vs. NG tube feedings) in a
population of pre-adolescents and adolescents with a hospital admission diagnosis of AN. The
clinical outcome measures are length of stay (LOS), weight gain, and suspected refeeding
syndrome.
Participants/Setting: The study sample includes 64 patients between the ages 9 and 20 years
who have been admitted to Children’s Healthcare of Atlanta between January 1, 2014 and
December 31, 2015 for clinical treatment of AN. The demographic, anthropometric, mode of
nutrition therapy and clinical characteristics of the patient population were obtained.
Statistical Analysis: Frequency statistics were used to describe demographic, anthropometric,
mode of nutrition therapy and clinical characteristics of the patient population. A Student’s t-test
was used to examine differences in continuous variables by tube feeding status, while a MannWhitney U test was used for the non-normally distributed variables. A Chi-square test was used
to examine differences in tube feeding status by categorical variables.
Results: Data were collected and analyzed for 64 patients, with a mean age of 14.6 + 2.4 years,
and the majority of the population being female (93.8%) and Caucasian (92.2%). Approximately
half (n=30, 47%) of the population received an NG tube during the admission. Mean discharge
BMI was significantly higher in those who received an oral diet vs. NG tube (16.67 vs. 17.08,
respectively; p=0.042) while weight change was significantly lower (1.3 kg vs. 2.1 kg,
respectively; p=0.012) and LOS shorter (8 days vs. 11 days, respectively; p=0.002)
There were no significant differences in other characteristics by mode of nutrition therapy.
Conclusion:

NG tube feeding is an effective method for feeding hospitalize adolescent patients with AN to
yield greater weight gain results. Future studies are necessary to determine the amount of time
exclusively on the NG tube, reasons for choosing NG vs. oral feedings, and other variables
associated with weight gain and length of stay.
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Chapter I
Differences in Nutritional Outcome Measures between Preadolescents and Adolescents with
Anorexia Nervosa who received a Nasogastric Feeding Tube versus Oral Diet upon Hospital
Admission
Introduction
The fifth edition of Diagnostic and Statistical Manual of Mental Disorders (DSM-5),
includes diagnostic description of six eating disorders including pica, ruminant disorder,
avoidant/restrictive food intake, anorexia nervosa (AN), bulimia nervosa, and binge-eating
disorder.1 Anorexia nervosa and bulimia nervosa account for approximately 80% of all diagnosed
eating disorders.1 AN is a disease defined by an extreme weight loss due to an intense fear of
gaining weight.2 The population most commonly diagnosed with AN are female adolescents with
an estimated prevalence of 0.5% in the United States.3 AN is the third most chronic disease in
adolescent females,4 with a mean mortality rate of approximately 2-5%.1,5 The condition peaks in
early- to mid-adolescence,5 and has a lifetime prevalence of 0.9 to 2.3% in the United States.6
Hospitalizations are common among patients with AN due to the major consequences
that can arise from having the disease.7 Complications include renal impairment, dental problems,
gastrointestinal, metabolic and respiratory impediments, heart complications and neuroendocrine
changes,1 in addition to growth retardation and decreased brain function.5 Most of these problems
can be resolved with significant weight gain. Although treatment often focuses on the restoration
of weight and nutrition status, it is important to closely monitor the clinical response to treatment
to avoid metabolic complications, such as refeeding syndrome, that can occur from a rapid influx
of calories in patients who are severely malnourished..1 Treatment options include outpatient
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therapy, partial hospitalization with continued outpatient therapy, residential treatment
centers, and inpatient hospitalization.3
Inpatient hospitalization is indicated when there is a serious medical need and is also
considered to be a last resort treatment option after failure to gain proper weight in an outpatient
setting.3 An interdisciplinary approach is used in hospital settings utilizing a team of
pediatricians, mental health specialists and registered dietitians.8 Criteria for hospital treatments
are dependent upon the medical status and compliance of the patient. If oral feeding does not
result in weight restoration, treatment may include implementation of nasogastric (NG) tube
feedings.3 Some hospitals have implemented supplemental nocturnal NG tube feeding, cyclic NG
tube feeding, and continuous NG tube feeding protocols. Potential risk factors related to the
implementation of enteral nutrition support during an inpatient hospitalization for AN have not
yet been determined. Although the use of an NG tube feeding has resulted in greater weight gain,
the results of studies that have examined the effect of enteral nutrition support on other outcome
measures such as length of stay have been inconsistent.4,9,10 The purpose of this study is to
examine the association between demographic and clinical characteristics and mode of nutrition
therapy in a population of pre-adolescents and adolescents with AN admitted to Children’s
Healthcare of Atlanta (CHOA) between January 1, 2014 and December 31, 2015. In addition, the
association between initiation of an NG tube feeding and outcome measures including length of
stay (LOS), weight gain, and clinical treatment for the prevention of refeeding syndrome will be
determined.

Specific Aim 1: Describe the demographic and anthropometric characteristics of pre-adolescents
and adolescents (ages 9-20) with AN admitted to CHOA by mode of nutrition therapy (NG tube
feeding vs. oral diet).
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Research Hypothesis 1A: Patients with AN who were categorized upon admission as
having a severe or extreme BMI classification will be more likely to have received an NG
tube during the admission vs. those with a mild or moderate BMI classification.
Null Hypothesis 1A: The number of patients with AN who received an NG tube feeding
during the admission will not differ by admission BMI classification.

Specific Aim 2: Examine the differences in outcome measures including weight gain and length
of stay (LOS) between preadolescents and adolescents with AN admitted to CHOA who received
an NG tube vs. those who received an oral diet with high-energy liquid supplements.

Research Hypothesis 2A: Patients who received an NG tube during the admission will
have a greater weight gain during admission than patients who were orally fed.
Null Hypothesis 2A: Weight gain during admission will not differ by mode of nutrition
therapy.

Research Hypothesis 2B: Patients who received an NG tube will have had a shorter LOS
than the patients who were orally fed.
Null Hypothesis 2B: Length of stay will not differ by mode of nutrition therapy.

Chapter II
Literature Review
Diagnostic Criteria for Anorexia Nervosa
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for
diagnosis of AN includes the following: amplified drive for thinness, intense fear of gaining
weight or becoming fat,8 restriction of energy intake relative to requirements, engaging in
persistent behavior that interferes with weight gain, and lack of recognition.11 This criteria also
includes the role of context such as sex, age, and developmental status in determining if an
individual as a significantly low weight.11 If a patient does not state a fear of gaining weight, the
diagnosis can still be made if he/she exhibits any type of behavior that interferes with weight
gain.1 The major change in diagnostic criteria from the older DSM-IV version was the removal of
the amenorrhea criteria because there was a lack of clinical use.1 DSM-5 diagnostic criteria uses
body mass index (BMI) to further diagnose levels of severity within this population. The
diagnostic levels of BMI for AN are as follows: extreme (BMI < 15 kg/m2), severe (BMI 15–
15.99 kg/m2), moderate (BMI 16–16.99 kg/m2) and mild (BMI > 17 kg/m2).11 For children and
adolescents, it is more accurate for clinicians to use BMI percentiles. The percentiles are defined
as thinness grade 2 (<3rd percentile), thinness grade 1(3rd-16th percentile), normal weight (16th-85th
percentile), overweight (85th–95th percentile), and obesity (BMI >95th percentile).12 There are
two sub classifications of AN, restrictive type and binge-eating/purging type. Restrictive type is
classified as restricting oral intake with or without compulsive exercise, and binge eating/purging
type is classified as exhibiting episodes of uncontrolled overeating concurrent with vomiting,
laxative, or diuretic misuse.5
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The pediatrician plays an important role in the screening process for AN by examining
height and weight trends.3 The pediatrician can also utilize questionnaires about eating patterns
and body satisfaction to further diagnose the presence of an eating disorder. Pediatricians are
among the most common health care providers to diagnose children and adolescents with an
eating disorder. Once a patient is diagnosed with AN, the pediatrician typically determines the
severity of the disease from evaluation of medical and nutrition laboratory values. It is
recommended that pediatricians look at heart rate, blood pressure, complete blood cell count,
electrolyte measurements, liver function tests, thyroid-stimulating hormone tests, and urinalysis
test.3
Complications Associated with Anorexia Nervosa
If AN is not diagnosed early in the course of the disease or treatment is not initiated in a
timely manner, major complications can arise. These complications are in part why many
adolescents are hospitalized and need immediate treatment.13 Some complications include renal
abnormalities such as increased blood urea nitrogen (BUN) values, increased risk of renal stones,
polyuria, and sodium and potassium depletion.3 Patients may also experience gastrointestinal
problems such as delayed gastric emptying, slowed gastrointestinal motility, constipation,
bloating, and hypercholesterolemia.3 Patients with AN may experience dental enamel erosion,
metabolic, and respiratory impediments,1 in addition to growth retardation and decreased brain
function.5 One of the most serious, yet most common, concern for adolescents diagnosed with
AN is the neuroendocrine changes that affect bone metabolism and reproductive functioning.
Increased bone metabolism can result in an increased risk for bone fractures1 and later risks for
osteoporosis.5 Osteopenia is prevalent in 90% of adolescents and young adults with AN, and this
is so concerning because the effects of osteopenia are not completely reversible.14 Reproductive
function can be inhibited due to calorie restriction in female adolescents causing amenorrhea.3
Resumption of menses can occur with a weight restoration of approximately 90% of ideal body
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weight.14 Cardiac events such as heart failure and cardiac arrest are also major concerns within
this patient population, and these problems can become so severe that the patient can endure a
coma or even dealth.1 In addition to the effects on bone metabolism, most of the aforementioned
problems can be resolved with significant weight gain.
In a malnourished state, resting energy expenditure can decrease by 50-70% of predicted
estimated needs; therefore, the initial calorie requirement is very low.14 One common
complication that can occur when increasing the calorie intake of patients with malnutrition is
refeeding syndrome. Refeeding syndrome occurs with an influx of calories creating a major shift
in electrolytes and fluids. These shifts in electrolytes can cause hypokalemia, hypophosphatemia,
and hyponatremia, which can result in muscle weakness4 and cardiac, neurological, or
hematological issues resulting in coma and death in most severe cases.15 The diagnosis of
refeeding syndrome based upon plasma levels of phosphorous, potassium, and magnesium (Table
1).
Table 1. Laboratory Criteria used in the Diagnosis of Refeeding Syndrome16

Electrolytes

Normal levels

Levels at risk for refeeding
syndrome

Serum phosphorus

2.5-4.5 mg/dL

<2.5 mg/dL

Serum potassium

3.5-5.2 mEq/L

< 3.5 mEq/L

Serum magnesium

1.6-2.4 mEq/L

<1.6 mEq/L

Fluid overload can cause edema and even cardiac failure. The more malnourished the patient is,
the higher the risk for refeeding syndrome upon hosptalization.4 Six to seven percent of patients
with AN experience refeeding syndrome, and patients who are typically <70% IBW, experience
hypophosphatemia in the first two weeks of hospitalization.15
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Another issue arising from feeding malnourished patients is the change in body
composition. Most of the weight gained during refeeding, especially in an inpatient setting, is fat
mass.14 The majority of the weight that is gained during the first couple of months appears to be
lean muscle and the closer to ideal body weight that the patient reaches, the greater the ratio of fat
to lean muscle is gained. Research has shown that the fat mass that is accumulated does not
exceed that of healthy controls is appropriate for rehabilitation purposes.14 Conversely, if calorie
administration is initially too low, than the patient may be underfed which may result in further
weight loss and increase the risk for cardiac problems.4 Underfeeding and overfeeding can cause
serious issues in malnourished patients; therefore, many studies have looked at different calorie
prescriptions to determine the initial nutrition prescription at admission to avoid developing
refeeding syndrome or other complications.
Treatment Options for Anorexia Nervosa
Treatment options for AN must be individualized for each patient. Treatment is most
successful with the utilization of a multidisciplinary team approach including physicians,
psychologists/psychiatrists, and dietitians.8 The role of the dietitian is to utilize the Nutrition Care
Process to identify nutrition diagnoses and establish a strategy for proper weight restoration.8 The
most simple, minimally invasive treatment option is outpatient care. The main goal for outpatient
care is weight restoration of 0.2-0.5 kg per week to prevent severe complications from arising.14
For patients either not gaining weight or not complaint with outpatient therapy, treatment may
resort to more intense options such as partial hospitalization, inpatient hospitalization, or
residential treatment centers.13
Partial hospitalization may be required for immediate care for patients that have not
succeeded with outpatient care but are not in a severe enough state that they need 24 hour
hospitalization.3 Partial hospitalization monitors meals during the day, provides therapy (i.e.,
psychological and medical nutrition therapy), and engages the patients in activities with other

8
patients with AN. This type of treatment can last a few hours a day for 2-4 days up to 4-5 days of
8 hour supervision.3 Inpatient hospitalization is required for patients with AN who exhibit acute
medical instability (i.e., low blood pressure, severe bradycardia etc.). Inpatient hospitalization
focuses on weight restoration, metabolic recovery to an anabolic state,14 corrections of electrolyte
balance, and reversal of any damage done from malnutrition.6 Weight restoration is achieved by
steadily increasing calorie intake to obtain a weight gain of 0.9-1.4 kg/week.14 Calorie
requirements in a patient that is malnourished may be as low as 1000-1400 kcals/day, however, it
is the goal of treatment facilities to increase this amount every 24-48 hours to achieve an intake
approximately 130% of estimated needs for metabolic recovery.14 All treatment options are
dependent on the patient’s immediate needs and level of health, and rehabilitation should be
tailored individually.
Inpatient Hospitalization Criteria and Protocols
According to the American Academy of Pediatrics,3 the patient must be diagnosed with
AN and exhibit one of the following symptoms for inpatient hospitalization: severe malnutrition
where the patient is <75% of the average body weight for height, and gender, dehydration,
electrolyte disturbances such as hypophosphatemia, hypokalemia, and hypomagnesemia, or
cardiac dysrhythmias. In addition, a patient diagnosed with AN meets admission criteria if they
show signs of physiological instability such as severe bradycardia (HR <50 bmp during daytime,
<45 bpm during nighttime), low blood pressure (<80/50), low temperature (<960F), or a change in
pulse or blood pressure by >20 bpm or 10 mmHg, respectively. Acute medical conditions such
syncope, seizures, cardiac failure, and pancreatitis can also warrant the need for hospitalization.
Furthermore, patients with AN may be admitted if outpatient treatment was not successful, if
patients are exhibiting slowed physiological development, refusing food, or displaying signs of
depression or suicidal tendencies. In addition to a weight restoration goal of 0.9-1.4 kg/week,13
the healthcare team also focuses on normalizing eating patterns and correcting physiological
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problems pertaining to malnutrition.17 After admittance to the hospital, the healthcare team will
determine the mode of feeding and the initial nutrition prescription.14 The healthcare team will
also frequently monitor nutrition labs and increase the calorie prescription every 24 to 48 hours as
tolerated until the patient is stabilized enough for discharge.5,14
Nutrition Treatment Options
When a patient is hospitalized for AN, it is up to the healthcare team to decide which type
of feeding would be most beneficial for the patient to yield proper weight restoration and
normalize eating behaviors. The different types of feeding patterns that have been studied are oral
diet with food and high-energy supplement drinks, nasogastric tube feeding, and parenteral
nutrition (PN).14 Research has shown that there are many benefits and disadvantages to each type
of feeding mechanism.18 When choosing a form of feeding mechanism, the decision is based
upon recommendations by the healthcare team and desires of the patient and family. After the
age of 18 patients are able to make their own healthcare decisions.

Oral feeding
Oral feeding is one of the most common feeding mechanisms used in medical inpatient
treatment facilities for AN.18 The advantages of oral feeding is that it acts as a teaching skill for
normalizing eating behaviors, it is easier to manage by the healthcare team, and it is the least
invasive treatment option.18 On the other hand, less energy may be provided from food when
compared to NG feeding or parenteral nutrition, because patients may continue to refuse food and
weight restoration is slowed.18 The Academy of Nutrition and Dietetics recommends that calorie
prescriptions should be initiated at 1200 kcals/day and progressed based on tolerance.19
According to the Children’s Healthcare of Atlanta Clinical Practice Guidelines (Appendix A),
calorie recommendations for patients receiving NG feedings begin at 30-40 kcals/kg and increase
over time as tolerated. For example, for a patient weighing 40kg, the initial caloric prescription
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would be ~1200-1600kcals/day. Few studies have examined oral diet administration and the
impact of different calorie levels on weight restoration, length of stay, and prevalence of
refeeding syndrome. However, some of these studies have evaluated an initial calorie prescription
greater than 1200 kcals and the impact on outcomes.15,17,19
Golden et al (2013)15 looked at adolescents and young adults, ages 10 to 21 years, that
were admitted to the hospital for AN. This study assessed patients that were started at a
prescription diet of >1400 kcals/day compared to those given <1400 kcals/day. Both groups had
caloric increases of 200 kcals every 24-48 hours. The researchers decided to use this calorie range
based on the evidence that refeeding syndrome occurs with calorie initiation >1400 kcals/day in
malnourished patients. They found that starting patients at an average of 1500 kcals a day resulted
in a shorter length of stay (13.0+7.3 days vs. 16.0+9.0 days; p=<0.0001). There were no
differences in total weight gain between the lower calorie group (3.6 kg +2.3) and the higher
calorie group (2.9 kg +1.9; p= .01) and rate of change in mean BMI (mBMI) was not significantly
different. No subjects experienced refeeding syndrome; however 15.8% of the patients developed
hypophosphatemia, 15.2% developed hypomagnesemia, and 20% developed hypokalemia. There
were no significant electrolyte differences between the low and higher calorie groups.15
Garber et al (2013)19 also compared lower calorie diets (800-1200 kcals) to higher calorie
diets (1400-2400 kcals) and found similar results. Calorie prescription was advanced by 122 + 8
kcals per day for the higher calorie group, and 98 + 6 kcals per day for the lower calorie group.
The rate of weight gained nearly doubled in the higher calorie group (0.27 kg + 0.03) in
comparison to the lower calorie group (0.14 kg + 0.02) per day (p < .001). The patients with AN
who received the lower calorie diet initially lost weight and did not start gaining weight until day
8 of their hospital stay. The higher calorie group also had a shorter length of stay (5.7 days
shorter; p < 0.001), with a higher calorie prescription at discharge (250 kcals greater). In both
groups there were no signs of refeeding syndrome. However, 45% of the patients had low serum
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phosphorus levels, but there was no significant difference between the two diet prescription
groups.19
Whitelaw et al (2010)20 and reported that initiating nutrition at 1900 kcals a day was
effective for weight restoration, but 37% required phosphate supplement. Therefore, Leclerc et al
(2013)17 conducted a study that initiated nutrition at 1500 kcals/day. The calorie prescription was
advanced by 250 kcals on days two and three, and every other day until day seven. He observed
that there was an average weight gain of 0.24 kg/day and only 3.5% of the patients needed a
phosphate supplement. No patients experienced refeeding syndrome, no other electrolyte
imbalances were observed, and average weight restoration was 1.7 kg/week.17 From these studies,
it appears that oral feeding can yield effective and beneficial results if calories are initiated at
approximately 1500 kcals per day and progressed as tolerated.15,17,19

Enteral Feeding
Due to the complications associated with oral feeding such as food refusal and slow rate
of weight gain, some hospitals have initiated NG tube feeding as a mechanism for feeding
patients with AN. NG tube feeding has a history of effective use in treating conditions such as
cancer, cystic fibrosis, and Crohn’s disease and has also been considered to be a proper treatment
option for AN.9 Different types of NG tube feeding regimens have been studied, including
continuous, nocturnal, and cyclic administration.4,9,10 Agostino et al (2013)4 examined continuous
NG tube feeding (NG group) averaging an initial calorie intake of 1617 kcals/day compared to
oral intake (bolus-fed group) averaging 1069 kcals upon admission. Of the patients receiving the
NG tube, 94% of the subjects were female. NG calorie administration started between 1500-1800
kcal/day and increased by 200 kcals per day until the maximum calorie intake was achieved or
patients had completed seven days on the NG tube. The bolus-fed group was started at 1000-1200
kcals/day, and increased by 150 kcals/day. This study found that the NG group had an average
weight gain rate of 1.22 kg/week in the first week vs. 0.08 kg/week for bolus-fed group. Fifty-one
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percent of the bolus group either lost weight or gained no weight during the first week, and only
6% in the NG group lost or gained no weight. The length of stay was also significantly lower in
the NG group (33.8 + 11 days) compared to the bolus group (50.9 + 24 days; p=0.0002). There
were no incidences of refeeding syndrome in either group.4
Robb et al (2002)9 compared female patients with AN that were fed orally during the day
with supplemental nocturnal NG feeding to those receiving only oral feedings during the day.
Males were excluded from this study because of the limited number of males with AN. Orally fed
patients were given a calorie prescription designed to promote weight gain of 1 to 2 kg/week. NG
supplementation was given at a rate of 1.5 kcal/ml. On the first night the patients were receiving
600 kcals from the NG tube in addition to the daily oral feedings. The second night provided
1080 kcals and the third and all other succeeding nights supplemented the patient with 1200 kcals
until discontinuation. NG feeding was ceased if the patient had reached 95% of his or her ideal
body weight or 3 to 4 days prior to discharge. Despite both groups having similar lengths of stay
(22.3 + 13.5 days for NG group vs 22.1 + 9.4 days for oral group), the NG supplemented group
had a greater weight gain (5.4 + 4 kg vs. 2.4 kg + 1.8 kg; p= 0.0001).9
Rigaud et al (2007)10 studied a supplemental cyclic NG regimen in addition to oral
feedings and compared this group to only orally fed patients. Of the patients receiving cyclic NG
regimen, 97% of the patients were female. Both groups were randomized to treatment with the
main weight gain goal set at 1 kg/week. The cyclic NG group received cyclic enteral nutrition in
the morning and/or afternoon hours. The cyclic NG group had better results concerning rate of
weight gain (194 + 14 g/day vs. 126 + 19 g/day), weight gain (1.0 vs. 0.77 kg/week), and fat-free
mass gain (56% vs. 49%; p < 0.01). This study did not examine LOS between the two groups.10
NG feeding is more invasive than oral feedings and patients may have trouble
maintaining the weight they gained once the tube is removed. NG tube feeding also increases the
risk for aspiration, nasal bleeding, reflux, and sinusitis.18 However, from the aforementioned
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studies, NG tube feeding can be a more effective and efficient mechanism for weight restoration,
but there is always a risk for refeeding syndrome.4,9,10,21

Parenteral Nutrition
Several studies have evaluated the effectiveness of PN on weight restoration in patients
with AN. Diamanti et al (2008)22 examined patients with AN that were given 40 kcal/kg/day of
PN, increasing to 60 kcal/kg/day by the end of week 1. Once the patients were receiving 50
kcal/kg/day, they were tapered off of the PN and given oral food. These patients were compared
with a group of patients who were exclusively oral fed. Weekly weight gain was greater for the
PN group (714.5 + 13.4 g/week vs. 531.0 + 8.2 g/week; p<0.0001) and the maximum caloric
intake was also greater for those receiving PN (2175 + 25.63 kcals vs. 2078 + 37.15 kcals;
p<0.0001). Even though the PN group sustained a greater weekly weight and higher calorie
intake, the number of complications was also significantly higher than the oral fed group
(p=0.004). All complications were resolved; however, some patients on PN experienced
dangerous hypophosphatemia, hypopotassemia, leg edema, infections, and increases in liver
enzyme levels. In addition to complications, the cost of the PN treatment was almost double the
cost of oral treatment.22
Hotta et al (2014)23 looked at PN for treating patients at home after they were discharged
from the hospital. They found that the most common problems with PN was the rate of infections
(4 out of 7 case reports) and the expense of the treatment was costly.23 PN is rarely used in a
clinical setting for patients with AN because of medical complications associated with this
treatment such as infection, cardiac arrhythmias, changes in vascular endothelium, and arterial
injury.18 This is a very medically invasive and expensive treatment option without many proven
benefits in this population.18
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Other variables that were collected from the EHR included race, anthropometric
measures (admission height in cm, admission weight in kg), calculated admission BMI,
admission BMI category, and at risk for refeeding syndrome. Treatment for the
prevention of refeeding syndrome was determined by those who were given any
supplements (potassium, phosphorus, magnesium) to treat refeeding symptoms, whether
or not refeeding syndrome was diagnosed. Admission BMI was categorized as Mild
(BMI >17), Moderate (16-16.99), Severe (15-15.99) and Extreme (<15). De-identified
patient data will be recorded onto a Microsoft Excel spreadsheet. Each patient was
assigned a numeric identification code chosen at random. Exempt approvals from the
IRB at Georgia State University and CHOA were obtained.

Statistical Analysis

The demographic, anthropometric, mode of nutrition therapy and clinical
characteristics of the patient population were described using frequency statistics.
Normality statistics was conducted on continuous variables (age, weight, height, LOS) to
determine the appropriate descriptive measure of central tendency. A Student’s t-test was
used to examine differences in continuous variables by tube feeding status. For nonnormally distributed data, a Mann-Whitney U test was conducted. The Chi-square test
was used to examine differences in tube feeding status by categorical variables (gender,
race, BMI category, treatment to prevent refeeding syndrome). All statistical analyses
were performed using SPSS (version 23.0, SPSS, Inc., Chicago, IL). A p-value of <0.05
is considered statistically significant.

Chapter III
Methods
Sample Population
The study sample includes pre-adolescents and adolescents between the ages 9 and 20
years of age who were admitted to CHOA for clinical treatment of AN. All patients have been
clinically diagnosed using the American Psychiatric Association’s diagnostic classification under
DSM-5 criteria. Patients with the Restricting Type and Binge-Eating/Purging Type of AN were
included. Exclusion criteria include patients diagnosed with an eating disorder other than AN,
including bulimia nervosa or binge eating disorder. Children with these conditions were excluded
as they exhibit symptoms other than energy restriction alone, such as binging, purging, and
laxative use. Patients whose length of stay was less than 2 days were also excluded from this
study. This sample population consists of children with AN who were admitted between January
1, 2014 and December 31, 2015.

CHOA Inpatient Protocol
The protocol for treating patients with AN upon admission at CHOA is adapted from
Texas Children’s Hospital protocol. This protocol begins with initiating an oral diet to promote
weight restoration > 90g per day for a minimum of four days (0.9-1.4 kg/week) (Appendix A).
The diet order is a Regular Diet with no diet products, no caffeine and no food labels. If a patient
does not achieve any weight gain within 48 hours of admission, then an NG tube feeding should
be administered. For patients between the ages of 1-13 years old, Pediasure Enteral formula is
generally used and for patients >14 years old, Osmolite may be used. NG caloric prescription is
usually initiated at 30-40 kcals/kg taking age and percent of ideal body weight into consideration.
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Caloric requirements and the enteral feeding rate (mL/hour) are determined by a Registered
Dietitian. Initially, caloric administration is started lower than the recommended hourly rate and
increased by 10 mL/hr every 4 hours until the goal rate is reached. Caloric intake is increased
over time based on the dietitian’s clinical judgment.

The NG group received a continuous NG infusion beginning 48 hours after admission
if there was no weight gain. For example, the NG feeding regimen for a patient weighing
40 kg would be as follows: (40 kg x 30 kcals/kg = 1200 kcals/day. 1200 kcals divided by
24 hours = 50 mL of Osmolite (for patients > 14 years of age). For patients who are
severely malnourished, NG administration may begin lower than the goal rate and
increased by 10 mL/hr. The control group received food and high-energy supplements.
Both NG and control groups were put on a 30-40 kcal/kg diet upon admission, and the
calorie prescription was increased as tolerated.
Patients with AN were considered ready for discharge if their overnight heart rate was
> 45 bpm, systolic blood pressure was > 90 and orthostatic heart rate changes were < 30
bpm. Additional discharge criteria included the patient must be asymptomatic, electrolyte
imbalances must be corrected, the patient no longer needs a phosphate supplement, and
the NG tube feeding must be discontinued 1-2 days prior to discharge. Follow up
psychiatric care must also established before discharge is approved.

Study Design

This study is a retrospective medical record review of patients diagnosed with AN
who were admitted to CHOA between January 1, 2014 and December 31, 2015. Data
were extracted from the CHOA electronic health record (EHR). Variables included
demographic characteristics (age in years, gender), LOS, and mode of nutrition therapy.

Chapter IV
Results
Data were collected and analyzed for 64 patients, with a mean age of 14.6 + 2.4 years
(range, 9 to 20 years). The majority of the population was female (93.8%) and Caucasian
(92.2%) (Table 1). The median length of stay was 9 days (range, 3 to 35 days). The data
distributions for age, admission weight, discharge weight, admission BMI, and discharge BMI
were normally distributed while length of stay, height, and weight change were skewed.
Table 1. Demographic and Anthropometric Characteristics for the Total Population
Characteristic

Total Population (N=64)

Gender [n (%)]
Female

60 (93.8)

Male

4 (6.3)

Race [n (%)]
Caucasian

59 (92.2)

African American

1 (1.6)

Other

1 (1.6)

Unknown

3 (4.7)

Age (years)*

14.6+ 2.4

Admission Weight (kg)*

41.3+9.26

Discharge Weight (kg)*

43.4+9.33

Height (cm)**

159.6 (154, 165)

Length of Stay (days)**
2

Admission BMI (kg/m )*
2

Discharge BMI (kg/m )*
Weight Change (kg)**

9.0 (6, 12.75)
16.03+2.44
16.89+2.38
1.7 (0.7, 3.1)

BMI – body mass index, kg – kilogram, cm – centimeter, m - meter
*Mean + SD; **Median (Interquartile range 25%, 75%)

The demographic and anthropometric characteristics by mode of nutrition therapy are
shown in Table 2. Approximately half (n=30, 47%) of the population received an NG tube during
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the admission. Mean discharge BMI was significantly higher in those who received an oral diet
vs. NG tube (16.67 vs. 17.08, respectively; p=0.042) while weight change was significantly lower
(1.3 kg vs. 2.1 kg, respectively; p=0.012) and LOS shorter (8 days vs. 11 days, respectively;
p=0.002). There were no significant differences in other characteristics by mode of nutrition
therapy.
Table 2. Demographic and Anthropometric Characteristics by Mode of Nutrition Therapy
Characteristic

Oral

NG Tube

P value

Age (years)*

14.7+2.25

14.5+2.64

0.418

Admission Weight (kg)*

42.4+8.75

39.94+9.79

0.306

Discharge Weight (kg)*

43.8+8.75

42.9+10.25

0.291

Admission BMI kg/m2)*

16.5+2.16

15.5+2.66

0.087

Discharge BMI (kg/m2)*

17.08+2.07

16.67+2.71

0.042

Length of Stay (days)**

8 (5%, 9.3%)

11 (7%, 21%)

0.002

Admission Height (cm)**

159.5 (154%, 165.6%)

159.75 (153.6%, 164.1%)

0.93

Weight change (kg)**

1.3 (0.4%, 2.3%)

2.1 (1.4%, 4%)

0.012

NG – nasogastric, BMI – body mass index, kg – kilogram, cm – centimeter, m – meter
*Mean + SD; **Median (Interquartile range, 25%, 75%)
Differences in mode of nutrition therapy by categorical variables (gender, race, BMI
category, treatment to prevent refeeding syndrome) are shown in Table 3. Treatment to prevent
refeeding syndrome was determined by those who were given any supplements (potassium,
phosphorus, magnesium) to treat symptoms, whether or not refeeding syndrome was diagnosed.
The number of days on an NG tube was significantly greater in children and adolescents who
were being treated for the prevention of refeeding syndrome vs. those who were not receiving
mineral supplementation (8.5 vs. 5.5 days, respectively, p= 0.046). Forty-one patients (64.1%)
received at least one supplement.
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Table 3. Demographic and Anthropometric Frequencies by Mode of Nutrition Therapy
Characteristics

Oral (n)

NG Tube (n)

Male

2

2

Female

32

28

Caucasian

31

28

African American

1

0

Other

0

1

Mild

15

11

Moderate

6

3

Severe

3

2

Extreme

10

14

Mild

19

12

Moderate

5

4

Severe

1

5

Extreme

9

9

Yes

21

20

No

13

10

P Value

Gender

0.897

Race

0.366

Admission BMI Category*

0.524

Discharge BMI category*

0.248

Treatment to Prevent Refeeding Syndrome

0.683

NG- nasogastric, BMI – body mass index
*BMI Category- Mild: BMI > 17 kg/m2, Moderate: BMI 16–16.99 kg/m2, Severe: BMI 15–15.99
kg/m2, Extreme: BMI < 15 kg/m2
The degree of malnutrition (Mild, Moderate, Severe, and Extreme) upon admission and
discharge by mode of nutrition therapy are shown in Figures 1-2. There was no significant
difference between the BMI categories and the mode of nutrition therapy received by the patient.
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Figure 1. Admission Body Mass Index Category by Mode of Nutrition Therapy
16

Number of Children

14
12
10
8
Oral

6

NG

4
2
0
Mild

Moderate

Severe

Extreme

BMI Category

BMI – body mass index, NG - nasogastric
Figure 2. Discharge Body Mass Index Category by Mode of Nutrition Therapy
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The differences between the admission BMI categories and discharge BMI categories for
those patients only receiving the NG tube are shown in Figure 3. No significant difference
between admission and discharge BMI categories was observed.
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Figure 3. Admission and Discharge Body Mass Index Category for Children with a Nasogastric
Tube
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Length of stay and weight change differed significantly by mode of nutrition therapy with
both variables being lower in patients who received an oral diet vs. NG tube during admission (8
days vs. 11 days, respectively; p=0.002 and 1.3 kg vs. 2.1 kg, respectively; p=0.012) (Figure 4).
Figure 4. Length of Stay and Weight Change by Mode of Nutrition Therapy
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Chapter V
Discussion
This study examined the association between demographic, clinical and anthropometric
characteristics by feeding method (NG vs. oral) in a population of hospitalized children and
adolescents diagnosed with anorexia nervosa. We found no significant difference in age, race,
gender or admission or discharge anthropometrics by the mode of nutrition therapy received. We
did observe a significantly longer LOS in those who received an NG tube. Patients who received
an NG tube also showed a significant greater weight gain over the course of the admission
compared to the exclusively orally fed group. This difference in weight change could be due to
the NG group having a greater LOS, and therefore more opportunity to gain weight. Length of
stay was not correlated with admission anthropometric measurements. Those that had a more
severe admission BMI category did not have a greater length of stay nor differ in mode of
nutrition therapy received. This could have been the result of some patients being discharged to
long-term care and rehabilitation facilities soon after they were stabilized, and weight gain status
and mode of nutrition was not representative of their full recovery. We observed no difference in
the number of patients who were treated for the prevention of refeeding syndrome by mode of
nutrition therapy. However, within the group of patients who received an NG tube, those who
received supplementation had a significantly greater number of days on the NG tube. We fail to
reject the null hypothesis that the number of patients who received an NG tube feeding during the
admission differed by admission BMI classification. We also fail to reject the null hypothesis that
LOS will not differ by mode of nutrition therapy. However, we do reject the null hypothesis that
weight gain during admission would not differ by mode of nutrition therapy.
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Our findings are consistent with those of Agostino et al. (2013), Robb et al. (2002), and
Rigaud et al. (2007)4,9,10, where patients who were receiving an NG tube had an overall greater
weight gain than the orally fed group. However, our results differed in observed LOS from
previous studies. Agostino found a shorter LOS in the NG group (33.8 + 11 days vs. 50.9 + 24
days) and Robb found similar lengths of stay between the NG and oral groups (22.3 + 13.5 vs.
22.1 + 9.4 days, respectively), where in the current study we observed a greater length of stay in
the NG group.
This study has several limitations. Our sample size was small and the study population
was comprised of predominately Caucasian females. Accordingly, the results may not be
generalizable to the general population of adolescents with eating disorders. Treatment for the
prevention of refeeding syndrome was assumed given mineral supplementation but no medical
diagnosis data were available. This is problematic because supplementation can be dependent on
other factors that do not necessarily lead to an association with refeeding syndrome.
Previous researchers have studied the importance of calorie administration at certain
levels and nutrition prescription advancement in the patient population with AN. In comparison to
the CHOA tube feeding protocol, not many studies have explained in depth the protocols used for
nutrition advancement. CHOA’s weigh gain goal was 0.9-1.4 kg per week in comparison to
Rigaud et al. (2007) 1kg/week and Robb et al. (2002) 1-2 kg/week weight gain goal.10,9 Riguad
used an indirect calorimetry to estimate needs, Agostino et al (2013) estimated needs anywhere
between 1000-1800 kcals based on age and mode of nutrition, and CHOA’s protocol estimated
needs around 30-40 kcals/kg.4 For our population, this calorie administration averages between
1200 and 1600 kcals. In Robb’s study, nutrition protocol was not discussed. With the limited
protocol information and the slight differences in nutrition prescriptions, it is challenging to
compare results in the effectiveness of one protocol over another.
Future studies should include multiple centers to achieve a greater sample size and a
more diverse population. Future research also needs to examine daily weight gain trends to
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observe weight gain difference and differences in caloric intake between days on the NG tube
versus days exclusively orally fed. It would also be beneficial to follow patients’ weight gain
process through other facilities such as rehabilitation facilities to monitor full progress. The
results of this study support initiation of an NG tube as part of the medical nutrition therapy plan
for hospitalized preadolescents and adolescents diagnosed with anorexia nervosa to yield a
greater weight gain outcome.
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